US Sex Reassignment Surgery Market Size, Share, Industry Trends, Outlook, Growth Opportunities and Market Forecast 2023 - 2030

U.S Sex Reassignment Surgery Market is Segmented By Surgery Type(Facial Feminization Surgery, Voice Surgery, Breast Augmentation, Genital Reconstruction, Others), By Gender Transition(Male to Female, Female to Male), By End Users(Hospitals and Medical Centers, Specialty Clinics, Others) – Share, Size, Outlook, and Opportunity Analysis, 2023 - 2030

Market Overview

U.S Sex Reassignment Surgery Market reached USD 2.1 billion in 2022 and is expected to reach USD 4.8  billion by 2030 growing with a CAGR of 11.4% during the forecast period 2023-2030. Sex reassignment surgery is also known as gender confirmation surgery and it is the most effective treatment for patients affected by gender dysphoria.

Sex reassignment surgery mainly involves gender transition procedures, including transitioning from male to female or female to male. The U.S. sex reassignment surgery market has witnessed significant growth in recent years. For instance, around 1.4 million transgender and non-binary adults and 150,000 transgender adolescents and young adults live in the United States and gender-affirming surgery has become increasingly performed over the past years for this growing population.

Facial feminization, breast augmentation, and genital reconstruction are common surgeries performed in the sex reassignment process. Furthermore, significant growth drivers such as the increasing transgender population, technical advancements, clinical trials, insurance coverage, and awareness among transgenders give rise to future market growth.

Market Scope

For More Insights about the Market Request Free Sample

Market Dynamics

Rising Transgender Population is Expected to Boost the U.S Sex Reassignment Surgery Market

The increasing population of transgenders in the U.S. have significantly played a major role in the growing demand for the sex reassignment surgery market. Sex reassignment surgeries are performed to give transgender individuals the physical appearance and functional abilities of the gender they prefer.

For instance, according to New York Times, a report based on C.D.C. health surveys published on June 10, 2022, it is estimated that 1.4 percent of 13- to 17-year-olds and 1.3 percent of 18- to 24-year-olds were transgender compared with about 0.5 percent of all adults. Experts also mentioned that young people increasingly have the language and social acceptance to explore their gender identities in the U.S.

Increasing Clinical Trials for Gender Dysphoria are Expected to Drive the  U.S Sex Reassignment Surgery Market 

According to ClinicalTrials.gov, on June 18, 2023, the University of Wisconsin, Madison conducted an interventional study on Trans Care titled “An online intervention to reduce symptoms of gender dysphoria”. The main aim is to improve the well-being of trans and nonbinary (TNB) individuals through an online intervention targeting the reduction of symptoms of gender dysphoria. The estimated study completion date is March 2025.

Additionally, on June 9, 2023, Vanderbilt University Medical Center conducted a clinical trial on Polyethylene-glycol Assisted Nerve Repair in Phalloplasty. Phalloplasty is a genitourinary surgery for transmasculine patients that reconstructs a neophallus using tissue transferred from other parts of the body to the groin. Polyethylene glycol (PEG) is a hydrophilic compound that enhances the fusion of the lipid bilayer membrane of severed axons, restoring the nerve's immediate ability to conduct electrical signals across the repair site.

Social Stigma Encountered by Transgenders Are Expected to Hamper U.S. Sex Reassignment Surgery Market Growth

According to National Center for Biotechnology Information, an article entitled Transgender Stigma and Health states that violence against US transgender people found that the prevalence of lifetime physical assault due to gender identity ranged from 33–53%. Similarly, according to the US National Coalition of Anti-Violence Programs, of the 18 anti-LGBT or HIV-related homicides in 2013, 72% of the victims were transgender women, and 67% were transgender women of color.

Segment Analysis

The U.S. sex reassignment surgery market is segmented based on surgery type,  gender transition, and end users.

Owing to the Rising Clinical Trials, Genital Reconstruction Surgery from the Surgery Type Segment Accounted for Approximately 28.1% of the U.S. Sex Reassignment Surgery Market Share 

The rising clinical trials of genital reconstruction surgeries in the U.S. have contributed to the growing demand for the sex reassignment surgery market. Genital reconstruction surgeries usually involve clitoridectomy, foreskin restoration, labiaplasty, vaginoplasty, and metoidioplasty. These surgeries are vitally important in the management treatment of gender dysphoria. 

For instance, according to clinicalTrials.gov, on May 18, 2023, Cedars-Sinai Medical Center conducted a clinical trial on the development of eeffective, opioid sparing techniques for peri-operative pain management of transgender patients undergoing gender affirming surgeries. This study compares the current standard-of-care pain treatment regimen options that are available to patients who undergo gender-affirming surgery. The estimated study completion date for this study is Aug 30, 2024.

Competitive Landscape

The major U.S players in the market include Mount Sinai Health System, Plastic Surgery Group Rochester, Boston Medical Center, Doernbecher Gender Clinic, CNY Cosmetic & Reconstructive Surgery, John Hopkins Medicine, Michigan Health System, Transgender Surgery Institute of Southern California, Moein Surgical Arts, Crane Center for Transgender Surgery among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the U.S. sex reassignment surgery market. During the height of the pandemic, many healthcare systems were overwhelmed, and non-urgent medical procedures and screenings were postponed or canceled. This led to delays in sex reassignment surgeries.

Clinical trials are vital for developing new treatments and improving outcomes in the U.S. sex reassignment surgery market. However, the pandemic disrupted the conduct of clinical trials, with many sites temporarily halting enrollment or modifying protocols to prioritize patient safety. This has led to delays in the completion of trials and the availability of new therapies.

Moreover, the focus of research and development efforts shifted during the pandemic, with a significant emphasis on developing vaccines and treatments for COVID-19. This diversion of resources and attention has temporarily impacted the progress of sex reassignment surgery research and development activities.

Also, to minimize the risk of COVID-19 transmission, healthcare providers implemented changes in treatment delivery, such as reducing in-person clinic visits, increasing telemedicine consultations, and modifying treatment schedules. Therefore, owing to the above factors, the U.S. sex reassignment surgery market is expected to be moderately affected over the forecast period.

By Surgery Type

• Facial Feminization Surgery
• Voice Surgery
• Breast Augmentation
• Genital Reconstruction
• Others

By Gender Transition

• Male to Female
• Female to Male

By End Users

• Hospitals and Medical Centers
• Specialty Clinics
• Others

Key Developments

• On Aug 10, 2022, U.S. Veterans Health Administration (VHA) offers gender-affirming care for around 10,000 of the country’s estimated 134,000 transgender veterans. VHA medical providers currently provide veterans with non-surgical gender-affirming care that includes hormone replacement therapy, prosthetics, voice therapy, and medical care before and after gender-affirming surgeries.
• On June 24, 2020, Northwestern Medicine launched the Gender Pathways Program, a clinical program for transgender and gender non-binary individuals providing supportive medical services from gender-affirming primary care to complex multidisciplinary surgeries. Feminizing and masculinizing facial, top, and bottom surgeries are offered in this program.

Why Purchase the Report?

• To visualize the U.S. sex reassignment surgery market segmentation based on the surgery type, gender transition, and end users as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of U.S. sex reassignment surgery market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The U.S sex reassignment surgery market report would provide approximately 69 tables, 70 figures, and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

For more Medical Devices related reports, please click here